Search for Master Regulators in Walking Cancer Pathways

Alexander E Kel1,2,3

  • 1Institute of Chemical Biology and Fundamental Medicine, SBRAN, Novosibirsk, Russia. alexander.kel@genexplain.com.

Insights

This study introduces an upstream analysis strategy to find master regulators in gene networks for identifying cancer drug targets. This method aids in understanding cancer development and drug resistance by analyzing multi-omics data.

Area of Science:

  • Bioinformatics
  • Systems Biology
  • Genomics

Background:

  • Identifying master regulators in gene regulatory networks is crucial for understanding pathological processes.
  • Current methods often lack a comprehensive strategy for causal analysis of multi-omics data.

Purpose of the Study:

  • To present an "upstream analysis" strategy for causal analysis of multi-omics data.
  • To identify master regulators in gene regulatory networks as potential drug targets for pathological conditions, specifically cancer.

Main Methods:

  • Utilizing a state-of-the-art promoter analysis with the TRANSFAC database for transcription factor (TF)-binding sites.
  • Analyzing upstream signal transduction pathways controlling TF activity.
  • Integrating transcriptomics and epigenomics data for multi-omics analysis.

Main Results:

  • The approach successfully identified potential key molecules (master regulators) controlling pathological states.
  • Demonstrated application on multi-omics cancer data revealed insights into cancer development and drug resistance mechanisms.
  • Highlighted the potential for rapid and accurate identification of cancer drug targets.

Conclusions:

  • The upstream analysis strategy offers a powerful approach for causal analysis of multi-omics data.
  • This method facilitates the discovery of novel cancer drug targets by identifying master regulators.
  • The approach enhances understanding of molecular mechanisms underlying cancer and drug resistance.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.8K